Predictive Oncology Inc [POAI] stock is trading at $0.75, up 8.75%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The POAI shares have gain 0.70% over the last week, with a monthly amount glided 1.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Predictive Oncology Inc [NASDAQ: POAI] stock has seen the most recent analyst activity on August 19, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $3.
Predictive Oncology Inc [POAI] stock has fluctuated between $0.55 and $3.76 over the past year. Predictive Oncology Inc [NASDAQ: POAI] shares were valued at $0.75 at the most recent close of the market.
Analyzing the POAI fundamentals
Predictive Oncology Inc [NASDAQ:POAI] reported sales of 1.38M for the trailing twelve months, which represents a drop of -51.66%. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -9.58%, Pretax Profit Margin comes in at -9.54%, and Net Profit Margin reading is -10.13%. To continue investigating profitability, this company’s Return on Assets is posted at -1.86, Equity is -3.04 and Total Capital is -3.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7087 points at the first support level, and at 0.6713 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7647, and for the 2nd resistance point, it is at 0.7833.
Ratios To Look Out For
For context, Predictive Oncology Inc’s Current Ratio is 1.20. In addition, the Quick Ratio stands at 1.06 and the Cash Ratio stands at 0.81. Considering the valuation of this stock, the price to sales ratio is 3.52, the price to book ratio is 2.48.
